Evidence map›Paper›PMID 27793142›Full record

ArticleMicrobial cell factories2016

Evaluation of gene expression cassettes and production of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) with a fine modulated monomer composition by using it in Cupriavidus necator.

Hisashi Arikawa, Keiji Matsumoto

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Engineering ofFrontiers in bioengineering and biotechnology · 2021
    Article
  18. Article
  19. Article
  20. Bioengineering (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Hisashi ArikawaGP Group, Corporate R&D Planning and Administration Division, KANEKA CORPORATION, 1-8 Miyamae-Cho, Takasago-Cho, Takasago, Hyogo, 676-8688, Japan. Hisashi.Arikawa@kaneka.co.jp.ORCID http://orcid.org/0000-0003-2212-8606
Keiji MatsumotoGP Group, Corporate R&D Planning and Administration Division, KANEKA CORPORATION, 1-8 Miyamae-Cho, Takasago-Cho, Takasago, Hyogo, 676-8688, Japan.
Takasago (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCupriavidus necator has attracted much attention as a platform for the production of polyhydroxyalkanoate (PHA) and other useful materials. Therefore, an appropriate modulation of gene expression is needed for producing the desired materials effectively. However, there is insufficient information on the genetic engineering techniques required for this in C. necator.

resultsWe found that the disruption of a potential ribosome binding site (RBS) in the phaC1 gene in C. necator caused a small decrease in the PhaC1 expression level. We applied this result to finely regulate the expression of other genes. Several gene expression cassettes were constructed by combining three Escherichia coli derived promoters (P

conclusionsWe constructed and evaluated several gene expression cassettes consisting of promoters and RBSs that finely regulate transcription and translation. These were then applied to finely modulate the monomer composition in the production of PHBHHx by recombinant C. necator.

Indexed as

3-Hydroxybutyric AcidCaproatesCupriavidus necatorEscherichia coliGene ExpressionGenetic EngineeringPolyhydroxybutyratesPromoter Regions, Genetic3-Hydroxybutyric AcidCaproatespoly(3-hydroxybutyrate-co-3-hydroxyhexanoate)PolyhydroxybutyratesCupriavidus necatorPHBHHxPolyhydroxyalkanoatesPromoterRibosome binding site

Identifiers

PMID27793142
PMCPMC5084369
OpenAlexW2541617984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.